EcoDrugPlus

Cholinergic Receptor, Muscarinic 5a

Ensembl ID : ENSORLG00000016873
Gene Symbol: CHRM5A
4 Cross references
195 Possible Orthologues:

Cholinergic Receptor, Muscarinic 5b

Ensembl ID : ENSORLG00000017845
Gene Symbol: CHRM5B
1 Cross references
189 Possible Orthologues:

Coagulation Factor Ii (Thrombin) Receptor

Ensembl ID : ENSORLG00000009766
Gene Symbol: F2R
1 Cross references
216 Possible Orthologues:

Coagulation Factor Iiia

Ensembl ID : ENSORLG00000004009
Gene Symbol: F3A
3 Cross references
199 Possible Orthologues:

Coagulation Factor Vii, Like

Ensembl ID : ENSORLG00000001157
Gene Symbol: F7L
4 Cross references
78 Possible Orthologues:

Coagulation Factor Xi

Ensembl ID : ENSORLG00000013680
Gene Symbol: LOC101167304
3 Cross references
208 Possible Orthologues:

Coagulation Factor Xi

Ensembl ID : ENSORLG00000013639
Gene Symbol: LOC101167055
3 Cross references
208 Possible Orthologues:

Coiled-Coil Domain Containing 6

Ensembl ID : ENSORLG00000005355
Gene Symbol: CCDC6
4 Cross references
207 Possible Orthologues:

Collagenase

Ensembl ID : ENSORLG00000020553
Gene Symbol: COLL
3 Cross references
283 Possible Orthologues:

Collagenase 3-Like

Ensembl ID : ENSORLG00000026048
Gene Symbol: LOC101159886
3 Cross references
231 Possible Orthologues:

Colony Stimulating Factor 1 Receptor, A

Ensembl ID : ENSORLG00000004849
Gene Symbol: CSF1RA
4 Cross references
63 Possible Orthologues:

Colony Stimulating Factor 1 Receptor, B

Ensembl ID : ENSORLG00000012809
Gene Symbol: CSF1RB
3 Cross references
204 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).